Choose your country

Grindeks search

International

Final Dosage Forms

Grindeks manufactures over 90 final dosage form (FDF) pharmaceutical products and exports these to over 70 countries worldwide. The portfolio contains both original and generic FDF products. Grindeks' FDFs range from solid form products, solution for injections to ointments and syrups.

*This section is intended for healthcare professionals only. This website contains information which is targeted to a wide range of audiences and could contain product details not accessible or valid in your country. We do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

A-Z
Alprazolam (under development)
  • Group

    Psycholeptics

  • ATC code

    N05BA12

  • Dosage and product form

    0.25 mg, 0.5 mg, 1 mg tablet

  • Brand name

    Zolomaks®, Alprazolam-Grindeks

Apixaban (under development)
  • Group

    Antithrombotic agents, Direct factor Xa inhibitors

  • ATC code

    B01AF02

  • Dosage and product form

    2.5 mg, 5 mg film-coated tablet

Apremilast (under development)
  • Group

    Selective immunosuppressants

  • ATC code

    L04AA32

  • Dosage and product form

    10 mg, 15 mg, 20 mg film-coated tablet

Betamethasone (under development)
  • Group

    Corticosteroids, Dermatological Preparations

  • ATC code

    D07AC01

  • Dosage and product form

    1 mg/g cream, ointment

Betamethosone/Calcipotriol (under development)
  • Group

    Antipsoriatics for Topical Use

  • ATC code

    D05AX52

  • Dosage and product form

    50 µg/0,5 mg/g gel, ointment

Bisacodyl (under development)
  • Group

    Drugs for constipation

  • ATC code

    A06AB02

  • Dosage and product form

    5 mg tablet

  • Brand name

    Bisacodyl-Grindeks

Bromhexine
  • Group

    Cough and Cold Preparations

  • ATC code

    R05CB02

  • Dosage and product form

    8 mg tablet

  • Brand name

    BROMHEXINE–GRINDEKS

Bupivacaine hydrochloride
  • Group

    Anesthetics

  • ATC code

    N01BB01

  • Dosage and product form

    5 mg/ml, 4 ml, 10 ml injection

  • Brand name

    Bupivacaine-Grindeks

Bupivacaine hydrochloride Heavy (under development)
  • Group

    Anesthetics

  • ATC code

    N01BB01

  • Dosage and product form

    5 mg/ml injection

Carvedilol
  • Group

    Beta blockers

  • ATC code

    C07AG02

  • Dosage and product form

    6.25 mg, 12.5 mg, 25 mg tablet

  • Brand name

    Karvidil®, Carvedilol-Grindeks

Clobetasol (under development)
  • Group

    Corticosteroids, Dermatological Preparations

  • ATC code

    D07AD01

  • Dosage and product form

    0.5 mg/g cream, ointment

Dapagliflozin (under development)
  • Group

    SGLT2 inhibitors, blood glucose lowering drugs

  • ATC code

    A10BX09

  • Dosage and product form

    5 mg film-coated tablet

Dexpanthenol
  • Group

    Treatment of wounds and ulcers

  • ATC code

    D03AX03

  • Dosage and product form

    50 mg/g  cream, ointment

  • Brand name

    Recreol®

Diazepam
  • Group

    Psycholeptics

  • ATC code

    N05BA01

  • Dosage and product form

    5 mg tablet

    5 mg/ml, 2 ml injection

  • Brand name

    Diazapeks®

Diclofenac gel (under development)
  • Group

    Topical products for joint and muscular pain. Anti-inflammatory preparations, non-steroids for topical use

  • ATC code

    M02AA15

  • Dosage and product form

    23.2 mg/g gel

Digoxin
  • Group

    Cardiac therapy

  • ATC code

    C01AA05

  • Dosage and product form

    0.25mg tablet

  • Brand name

    Digoxin-Grindeks

Dimetindene
  • Group

    Antihistamines for topical use

  • ATC code

    D04AA13

  • Dosage and product form

    1 mg/G 30 g gel

Eltrombopag (under development)
  • Group

    Thrombopoietin agonists

  • ATC code

    B02BX05

  • Dosage and product form

    25 mg film-coated tablet

Hydrocortisone (under development)
  • Group

    Corticosteroids, Dermatological Preparations

  • ATC code

    D07AB02

  • Dosage and product form

    1 mg/g cream

Imatinib mesylate
  • Group

    Antineoplastic agents

  • ATC code

    L01XE01

  • Dosage and product form

    100 mg hard capsule

  • Brand name

    Imatinib-Grindeks

Ketoconazole
  • Group

    Antifungals for dermatological use

  • ATC code

    D01AC08

  • Dosage and product form

    20 mg/g  shampoo

  • Brand name

    Mikanisal®

Lenalidomide
  • Group

    Multiple myeloma; immunosuppressants

  • Dosage and product form

    2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 25 mg hard capsule

  • ATC code

    L04AX04

Lidocaine hydrocloride
  • Group

    Local Anesthetics

  • ATC code

    N01BB02

  • Dosage and product form

    20 mg/ml, 5 ml injection

  • Brand name

    Lidocaine-Grindeks

Lisinopril (under development)
  • Group

    ACE inhibitors, plain

  • ATC code

    C09AA03

  • Dosage and product form

    2.5 mg, 5 mg, 10 mg, 20 mg tablet

  • Brand name

    Lisinopril-Grindeks

Loperamide (under development)
  • Group

    Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents

  • ATC code

    A07DA03

  • Dosage and product form

    2 mg hard capsule

  • Brand name

    Loperamide-Grindeks

Meldonium
  • Group

    Other cardiac preparations

  • ATC code

    C01EB22

  • Dosage and product form

    100 mg/ml injection/ampoules, 250mg, 500mg capsules

  • Brand name

    Mildronate®

Meldonium Phosphate
  • Group

    Other cardiac preparations

  • ATC code

    C01EB22

  • Dosage and product form

    500 mg tablets

  • Brand name

    Mildronate Gx®, Mildronat NEO®, Mildronāts®

Memantine hydrochloride
  • Group

    Psychoanaleptics

  • ATC code

    N06DX01

  • Dosage and product form

    10 mg film-coated tablet

  • Brand name

    Tingreks®, Memantine Grindeks

Methylprednisolone (under development)
  • Group

    Corticosteroids, Dermatological Preparations

  • ATC code

    D07AC14

  • Dosage and product form

    1 mg/g cream

Mometasone (under development)
  • Group

    Corticosteroids, Dermatological Preparations

  • ATC code

    D07AC13

  • Dosage and product form

    1 mg/g cream, ointment

Nilotinib
  • Group

    Antineoplastics, Protein kinase inhibitors

  • ATC code

    L01XE08

  • Dosage and product form

    100 mg, 200 mg capsule

Oxytocin
  • Group

    Pituitary and hypothalamic hormones and analogues

  • ATC code

    H01BB02

  • Dosage and product form

    5 IU,  10 IU,  1ml injection

  • Brand name

    Oxytocin-Grindeks

Pomalidomide (under development)
  • Group

    Immunosuppressant

  • ATC code

    L04AX06

  • Dosage and product form

    1 mg, 2 mg, 3 mg, 4 mg capsule

Ranolazine (under development)
  • Group

    Cardiac therapy

  • ATC code

    C01EB18

  • Dosage and product form

    375 mg, 500 mg, 750 mg tablet

Rilmenidine (under development)
  • Group

    Imidazoline receptor agonists

  • ATC code

    C02AC06

  • Dosage and product form

    1 mg tablet

Risperidone (under development)
  • Group

    Antipsychotics

  • ATC code

    N05AX08

  • Dosage and product form

    0.5 mg, 1 mg, 2 mg, 3 mg, 4mg, 6 mg film-coated tablet

  • Brand name

    Rispaxol®

Rivaroxaban (under development)
  • Group

    Antithrombotic agents, Direct factor Xa inhibitors

  • ATC code

    B01AF01

  • Dosage and product form

    10 mg, 15 mg, 20 mg tablet

Sitagliptin
  • Group

    DPP-4 inhibitors. Blood glucose lowering drugs

  • ATC code

    A10BH01

  • Dosage and product form

    25 mg, 50 mg, 100 mg tablet

Sitagliptin/Metformin
  • Group

    Combinations of oral blood glucose lowering drugs

  • ATC code

    A10BD07

  • Dosage and product form

    50 mg/850 mg, 50 mg/1000 mg tablet

Sulpiride
  • Group

    Psycholeptics

  • ATC code

    N05AL01

  • Dosage and product form

    50 mg, 100 mg, 200 mg tablet

Tegafur
  • Group

    Antineoplastic agents

  • ATC code

    L01BC03

  • Dosage and product form

    400 mg capsule

  • Brand name

    Ftorafur®

Terbinafine
  • Group

    Antifungals for dermatological use

  • ATC code

    D01AE15

  • Dosage and product form

    10 mg/g ointment

  • Brand name

    Terbital®

Ursodeoxycholic acid (UDCA)
  • Group

    Bile and liver therapy

  • ATC code

    A05AA02

  • Dosage and product form

    250 mg hard capsules

  • Brand name

    Grinterol®

Venlafaxine (under development)
  • Group

    Antidepressants

  • ATC code

    N06AX16

  • Dosage and product form

    37.5 mg,  75 mg, 150 mg, 225 mg  hard prolonged release capsule

  • Brand name

    Venlaxor®

Warfarin
  • Group

    Antithrombotic agents

  • ATC code

    B01AA03

  • Dosage and product form

    3 mg, 5 mg tablet

  • Brand name

    Warfarin-Grindeks

Zopiclone
  • Group

    Psycholeptics

  • ATC code

    N05CF01

  • Dosage and product form

    7.5 mg film-coated tablet

  • Brand name

    Somnols®, Sonlax, Zopitabs

We use cookies in order to offer you the best experience on our website. By continuing to use our website, you are agreeing to our use of cookies. Read more

Accept